Physician organizations have an ethical obligation to advocate for general improvement of public health, even if it is sometimes at the expense of interests of medical professionals.
Mark McClellan, Commissioner of Food and Drugs, discusses pharmaceutical company research and the problems faced by funding for public health programs.
Refusals of psychotropic medication by detained criminal defendants raise conflicting dual loyalties for psychiatrists between the duty to treat a patient and the duty to protect society from that patient.